Pathogenic variants of CACNA1C have been identified in subjects with intellectual disability, executive dysfunction, hyperactivity-impulsivity that interferes with Attention-Deficit/Hyperactivity Disorder (ADHD) and/or ASD, as well as forms of childhood-onset epilepsy (Damaj et al., 2015). This evidence concerns the gene CACNA1C and attention deficit-hyperactivity disorder.